Literature DB >> 8788416

Comparison of the peptide structural requirements for high affinity interaction with bombesin receptors.

J T Lin1, D H Coy, S A Mantey, R T Jensen.   

Abstract

Recently it has been established that both a gastrin-releasing peptide (GRP)-preferring bombesin receptor and a neuromedin B-preferring bombesin receptor mediate the mammalian actions of bombesin-related peptides. Because many tissues used for studies of the structure-activity relationship of these peptides possess both receptor subtypes and none possess only the neuromedin B-preferring subtype, there is minimal information on the peptide structural features determining receptor selectivity and it is unknown whether the determinants of agonism at both bombesin receptor subtypes are similar. In the present study we have used native cells either possessing only one bombesin receptor subtype or stably transfected with one subtype to study in detail the peptide structural requirements for interacting and activating each receptor subtype. For the naturally occurring agonists, at the GRP-preferring bombesin receptor the relative affinities were litorin = ranatensin = bombesin > GRP >> neuromedin B, phyllolitorin and at the neuromedin B-preferring bombesin receptor were litorin = neuromedin B = ranatensin > bombesin, phyllolitorin >> GRP. For the GRP-preferring bombesin receptor the heptapeptide and for the neuromedin B-preferring bombesin receptor the octapeptide was the minimal carboxyl fragment interacting with the receptor/or causing biologic activity, and the nonapeptide and full decapeptide, respectively, were the minimal required for full affinity. Making neuromedin B more bombesin- or GRP-like by replacing amino acids in position 3, 6, and 9 demonstrated that position 3 was the most important, followed by position 9 for receptor subtype selectivity. A conformationally restricted GRP analogue, [D-Cys6,D-Ala11,Cys14]bombesin-(6-14) had a significantly higher affinity for GRP-preferring bombesin receptor than NMB receptor. These results demonstrate that: (1) the structure-function relations for the two mammalian bombesin receptors have important differences; (2) suggest that the active conformation of neuromedin B must differ markedly from the beta-sheet model proposed for GRP; and (3) suggest that one important function of the NH2 terminus of GRP and neuromedin B is determining receptor subtype selectivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788416     DOI: 10.1016/0014-2999(95)00510-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Bombesin receptor-mediated imaging and cytotoxicity: review and current status.

Authors:  Veronica Sancho; Alessia Di Florio; Terry W Moody; Robert T Jensen
Journal:  Curr Drug Deliv       Date:  2011-01       Impact factor: 2.565

Review 2.  Insights into bombesin receptors and ligands: Highlighting recent advances.

Authors:  Irene Ramos-Álvarez; Paola Moreno; Samuel A Mantey; Taichi Nakamura; Bernardo Nuche-Berenguer; Terry W Moody; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2015-05-11       Impact factor: 3.750

Review 3.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

4.  Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.

Authors:  Hirotsugu Uehara; Nieves González; Veronica Sancho; Samuel A Mantey; Bernardo Nuche-Berenguer; Tapas Pradhan; David H Coy; Robert T Jensen
Journal:  Peptides       Date:  2011-06-28       Impact factor: 3.750

5.  The molecular basis for high affinity of a universal ligand for human bombesin receptor (BnR) family members.

Authors:  Hirotsugu Uehara; Simon J Hocart; Nieves González; Samuel A Mantey; Tomoo Nakagawa; Tatsuro Katsuno; David H Coy; Robert T Jensen
Journal:  Biochem Pharmacol       Date:  2012-07-22       Impact factor: 5.858

6.  Bombesin inhibits alveolarization and promotes pulmonary fibrosis in newborn mice.

Authors:  Khalid Ashour; Lin Shan; Jong Hwan Lee; William Schlicher; Keiji Wada; Etsuko Wada; Mary E Sunday
Journal:  Am J Respir Crit Care Med       Date:  2006-04-07       Impact factor: 21.405

Review 7.  Bombesin-drug conjugates in targeted therapy for small cell lung cancer.

Authors:  Yichi Zhang; Elizabeth Holland; Anna Dinh; Duc Au; Lichun Sun
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 8.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

9.  BR-bombesin: a novel bombesin-related peptide from the skin secretion of the Chaco tree frog (Boana raniceps) with physiological gastric effects.

Authors:  Nayara Alves de Sousa; Mariela M Marani; André Luís Fernandes Lopes; Emanuelle Morais Silva; Eder Alves Barbosa; Andreanne Gomes Vasconcelos; Felipe T B Kuzniewski; Suellen Sousa Lustosa; Karina Pereira Gomes; Diego Basile Colugnati; Jefferson A Rocha; Lucianna Helene Santos; Marcelo P Benquerer; Patrick Quelemes; Leiz Véras; Daniel C Moreira; Kalinne Kelly Lima Gadelha; Pedro Jorge Caldas Magalhães; Alexandra Plácido; Peter Eaton; Lucas Nicolau; Jand Venes R Medeiros; José R S A Leite
Journal:  Amino Acids       Date:  2022-03-13       Impact factor: 3.520

10.  Evolution of bombesin conjugates for targeted PET imaging of tumors.

Authors:  Hanwen Zhang; Keelara Abiraj; Daniel L J Thorek; Beatrice Waser; Peter M Smith-Jones; Michael Honer; Jean Claude Reubi; Helmut R Maecke
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.